Overview: Angiotensin II TestIntroduction: The Angiotensin II Test measures angiotensin II levels to evaluate conditions like high blood pressure or heart failure, which may cause fatigue or swelling. Aligned with 2023 AHA guidelines, it uses an immunoassay for high sensitivity, aiding in endocrine screening. This test is critical for guiding treatment, monitoring cardiovascular health, and improving outcomes in endocrinology for patients with suspected renin-angiotensin system disorders.
Other Names: Angiotensin II Assay, Renin-Angiotensin System Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Renin-angiotensin testing began in the 1970s. Angiotensin II assays emerged in the 1990s, and by the 2000s, immunoassays improved detection of cardiovascular disorders.
Purpose: Diagnoses hypertension or heart failure, guides treatment, and monitors angiotensin II levels in patients with fatigue or swelling.
Test Parameters: 1. Angiotensin II
Pretest Condition: Fasting for 10-12 hours required to stabilize hormone levels. Collect serum or plasma after overnight fasting. Report symptoms like fatigue or swelling, and list medications like ACE inhibitors.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document cardiovascular symptoms, hypertension history, or family history of heart disease. Include current medications, especially ACE inhibitors or ARBs.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for treatment or further testing.
Procedural Considerations: Uses an immunoassay to measure angiotensin II levels. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples or ACE inhibitors may alter results. Hemolysis or improper storage can degrade samples.
Clinical Significance: Elevated angiotensin II levels suggest renin-angiotensin system dysfunction, prompting treatment adjustments. Normal levels may require renin or aldosterone testing.
Specialist Consultation: Consult a cardiologist or endocrinologist for result interpretation. A nephrologist referral is advised for kidney-related issues.
Additional Supporting Tests: Renin test, aldosterone test, or echocardiogram to confirm hypertension or heart failure.
Test Limitations: False positives may occur with stress or medications. Results require clinical correlation with other cardiovascular markers.
References: AHA Hypertension Guidelines, 2023; Journal of the American College of Cardiology, Yancy CW, 2022.
